1. Introduction
Apical hypertrophic cardiomyopathy (ApHCM), also called apical HCM or Yamaguchi syndrome, is a phenotype of hypertrophic cardiomyopathy in which hypertrophy predominantly involves the left ventricular (LV) apex. It is classically associated with deep, sometimes giant, negative T waves in the precordial leads and may also produce T-wave inversion in inferior and lateral leads.
The ECG can raise suspicion, but it cannot independently confirm ApHCM. The diagnosis rests on demonstrating the characteristic distribution of LV hypertrophy with cardiac imaging and excluding alternative causes of myocardial thickening.
Marked precordial QRS voltage together with deep, often symmetric T-wave inversion—particularly across the mid-to-lateral precordial leads—should prompt consideration of ApHCM when the clinical context is compatible.
The supplied reference describes ApHCM as a usually non-obstructive variant and illustrates the classic “ace-of-spades” LV cavity configuration. However, apical HCM is not invariably free of mid-ventricular obstruction or apical complications; the complete phenotype must be assessed.
2. Electrophysiology and pathophysiology
Apical myocardial hypertrophy changes LV geometry and regional myocardial electrical properties. The resulting ECG commonly combines increased depolarisation voltage with abnormal ventricular repolarisation. The exact mechanisms producing the magnitude and distribution of T-wave inversion are not fully captured by a single surface-ECG explanation; regional hypertrophy, altered activation–recovery relationships, myocardial disarray and fibrosis may contribute.
Why the T waves become deeply inverted
- Prominent apical hypertrophy alters regional myocardial mass and repolarisation characteristics.
- Abnormal repolarisation vectors can produce marked negative T waves in precordial leads, often extending to inferior and lateral leads.
- Increased LV myocardial mass may produce high QRS voltage, although voltage criteria are neither required nor specific.
- Apical cavity obliteration during systole may accompany the hypertrophic phenotype and is best characterised by imaging rather than inferred from the ECG.
Structural correlate: the ace-of-spades sign
Marked thickening of the apical LV wall narrows the cavity toward the apex, while the mid-ventricular and basal cavity may remain relatively preserved. In ventriculography this can create a spade-like configuration, particularly in end-diastole. The configuration can also be demonstrated with echocardiography and cardiac magnetic resonance (CMR).
3. Characteristic ECG features
The ECG phenotype is variable. The following are typical clues rather than mandatory diagnostic criteria.
| ECG component | Typical observation | Interpretive value |
|---|---|---|
| Rhythm and rate | Often sinus rhythm; atrial fibrillation or other arrhythmias may occur. | Assess rhythm independently; sinus rhythm does not exclude disease. |
| QRS voltage | Large precordial voltages / LVH voltage pattern may be present. | Supports increased LV mass but is not specific for ApHCM. |
| ST segment | ST depression may accompany the repolarisation abnormality. | Interpret with symptoms, serial ECGs and troponin when acute ischaemia is possible. |
| T waves | Deep, often symmetric T-wave inversion in precordial leads; inferior and lateral inversion may coexist. | Classic ECG clue. Distribution and depth vary between patients. |
| Q waves | Abnormal Q waves can occur in HCM, but are not the defining feature of ApHCM. | Do not use Q waves alone to distinguish HCM from infarction. |
| QT interval | QTc may be prolonged in some patients with HCM. | Measure when relevant; it is not a defining ApHCM criterion. |
“Giant” T waves are often described as negative T-wave amplitude of at least 10 mm (1 mV), but this is a descriptive ECG term—not a stand-alone diagnostic threshold for ApHCM. Less dramatic or absent giant T waves do not rule out apical disease.
4. Systematic ECG interpretation
- Confirm technical quality and calibration. Check standardisation, lead placement and artefact. Misplaced precordial leads can alter R-wave progression and apparent repolarisation distribution.
- Identify rhythm and rate. Determine whether sinus rhythm is present and look for atrial fibrillation, ectopy or ventricular arrhythmia.
- Assess QRS voltage and morphology. Look for increased precordial voltage or other LVH features. Voltage alone is not diagnostic.
- Map the T-wave inversion. Record the exact leads involved, depth, symmetry and whether the pattern is contiguous across precordial, lateral and inferior territories.
- Evaluate for acute or alternative pathology. Compare with previous ECGs and assess symptoms, ST-segment changes, reciprocal patterns and biomarkers when acute coronary syndrome is possible.
- Integrate clinical context. Ask about exertional dyspnoea, chest discomfort, palpitations, syncope, family history of HCM or premature sudden death, and relevant loading conditions.
- Confirm with cardiac imaging. Request transthoracic echocardiography (TTE); use contrast-enhanced echo or CMR when the apex is not adequately visualised or the diagnosis remains uncertain.
“Sinus rhythm with increased precordial QRS voltage and deep T-wave inversion involving the precordial (± inferior/lateral) leads. In the appropriate clinical context, the pattern raises suspicion for apical hypertrophic cardiomyopathy; correlate with echocardiography and/or CMR. The ECG is not diagnostic in isolation.”
5. Diagnostic criteria and limitations
There is no ECG-only diagnostic criterion for ApHCM. The ECG is a clue that should lead to structural assessment. Diagnosis requires predominant apical LV hypertrophy on imaging and exclusion of alternative causes of hypertrophy.
| Domain | Finding used in assessment | Clinical interpretation |
|---|---|---|
| ECG support | LVH voltage and deep/giant T-wave inversion, often precordial and sometimes inferior/lateral. | Suggestive phenotype; neither required nor sufficient. |
| Conventional adult HCM definition | Maximal end-diastolic LV wall thickness ≥15 mm in any segment, without another cause sufficient to explain the hypertrophy. | General HCM definition; not a unique ApHCM ECG threshold. |
| Conventional ApHCM imaging pattern | Hypertrophy predominantly at the LV apex; commonly cited apical thickness ≥15 mm and apical-to-posterior wall thickness ratio ≥1.5. | Commonly used imaging criteria; interpret with morphology and image quality. |
| Relative / early ApHCM | Typical ECG and imaging phenotype, loss of normal apical tapering and/or apical cavity obliteration may be present despite apical thickness below 15 mm. | Emerging evidence cautions against excluding ApHCM solely because the 15-mm threshold is not reached. |
Apical thickness measurements are vulnerable to foreshortening and inadequate visualisation. A non-contrast TTE may miss apical hypertrophy. The 2024 AHA/ACC multisociety guideline considers an ultrasound-enhancing agent reasonable when apical HCM or an apical aneurysm is not clearly established by TTE; CMR is indicated when echocardiography is inconclusive in suspected HCM.
Conventional criteria are useful, but recent work has described “relative” ApHCM with characteristic ECG and imaging findings despite maximal apical wall thickness below 15 mm. A negative measurement at this threshold should not end the evaluation when the overall phenotype remains convincing.
6. Differential diagnosis
| Condition | Potential ECG overlap | Clues that help distinguish it |
|---|---|---|
| Acute coronary syndrome / myocardial ischaemia | Deep T-wave inversion, ST depression or evolving repolarisation changes. | Acute symptoms, dynamic serial ECG changes, troponin pattern and coronary assessment. Do not attribute new T-wave inversion to HCM without excluding ACS when clinically indicated. |
| Other HCM phenotypes | LVH voltage, ST–T abnormalities, pathological Q waves. | Imaging defines the distribution of hypertrophy; ApHCM is predominantly apical rather than septal or diffuse. |
| Hypertensive heart disease / aortic stenosis | LVH voltage with secondary ST–T “strain” changes. | History, blood pressure, valve assessment and imaging distribution. These are loading-related causes of LVH. |
| Takotsubo syndrome | Deep T-wave inversion and QTc prolongation can occur. | Acute clinical presentation, transient regional wall-motion abnormality and recovery on follow-up imaging; exclude ACS as appropriate. |
| Myocarditis | Non-specific ST–T abnormalities and T-wave inversion. | Clinical inflammatory/infective context, troponin and CMR tissue characterisation. |
| Neurological / other systemic causes | Deep widespread T-wave inversion may occur in selected acute neurological or systemic illness. | Clinical context and evaluation for the underlying condition; do not assume a primary cardiomyopathy. |
Juvenile T-wave patterns, athletic remodelling and other causes of increased voltage should also be considered in the appropriate age and clinical setting. The presence of T-wave inversion alone does not establish HCM.
7. Clinical significance, complications and red flags
ApHCM is not invariably benign. Many patients have a relatively stable course, but clinically important complications can occur and risk assessment should follow the overall HCM phenotype rather than the ECG appearance alone.
- Syncope or near-syncope, particularly during exertion or without a clear benign explanation.
- New or ongoing chest pain, acute dyspnoea, haemodynamic instability or dynamic ST–T changes.
- Sustained palpitations, documented sustained ventricular tachycardia, or resuscitated cardiac arrest.
- New neurological deficit or suspected systemic embolism.
- Known HCM with a family history of premature sudden cardiac death or newly identified high-risk imaging features.
8. Clinical evaluation and management principles
Initial assessment
- Obtain a detailed symptom history, including exertional chest pain, dyspnoea, palpitations and syncope.
- Document a three-generation family history of HCM, unexplained sudden death and relevant inherited cardiac disease.
- Perform physical examination and assess for dynamic LV outflow tract obstruction when clinically relevant; apical phenotype does not guarantee absence of obstruction.
- Review medications, blood pressure, comorbidities and potential alternative causes of LV hypertrophy.
Imaging and rhythm evaluation
- TTE: first-line imaging to assess distribution and magnitude of hypertrophy, LV function, cavity obliteration, apical aneurysm, obstruction and diastolic function.
- Contrast-enhanced echocardiography: reasonable when the apex or suspected apical aneurysm is inadequately characterised on standard TTE.
- CMR: indicated for diagnostic clarification when echocardiography is inconclusive; evaluates apical morphology, aneurysm and late gadolinium enhancement (LGE).
- ECG monitoring: 12-lead ECG at initial evaluation and follow-up; ambulatory monitoring to detect atrial fibrillation or ventricular arrhythmias according to symptoms and HCM risk assessment.
- Family and genetic assessment: consider genetic counselling/testing and cascade screening when HCM is diagnosed, following guideline recommendations.
Management principles
Treatment is individualised according to symptoms, obstruction, arrhythmia burden, LV function and sudden-death risk. Management may include symptom-directed pharmacotherapy, treatment of atrial fibrillation and thromboembolic risk, surveillance for apical aneurysm and ventricular arrhythmia, and consideration of an implantable cardioverter-defibrillator (ICD) when guideline-based risk assessment supports it. ApHCM alone, or a striking T-wave pattern alone, is not an indication for an ICD.
Refer to an HCM-experienced cardiology team for diagnostic uncertainty, significant symptoms, arrhythmia, apical aneurysm, systolic dysfunction or complex risk decisions. Acute coronary syndrome and haemodynamic instability require urgent pathways independent of a suspected underlying ApHCM diagnosis.
9. Common interpretation pitfalls
- Calling the ECG diagnostic: deep T-wave inversion is a clue, not proof of apical hypertrophy.
- Excluding ApHCM when giant T waves are absent: ECG expression is variable and imaging-defined disease may be present with less dramatic repolarisation changes.
- Missing the apex on echocardiography: foreshortened views or poor endocardial definition can conceal apical thickening or aneurysm.
- Assuming all ApHCM is non-obstructive: assess for mid-ventricular and LV outflow obstruction rather than relying on the historical label.
- Misdiagnosing acute ischaemia: chronic HCM-related repolarisation abnormalities can mimic ischaemia, but new symptoms or dynamic ECG changes still require appropriate ACS evaluation.
- Using a single wall-thickness cut-off rigidly: consider relative apical hypertrophy and the complete imaging phenotype.
- Equating ECG severity with sudden-death risk: risk stratification requires clinical history, family history, imaging and rhythm data.
10. ECG interpretation practice
Use the supplied authentic recordings to practise pattern recognition. The PDF does not provide full patient histories, measured intervals or detailed clinical outcomes for these ECG examples; therefore, no patient-specific scenario or unsupported numerical measurements are added here.
Knowledge check
Which combination most strongly raises suspicion for ApHCM on a 12-lead ECG?
11. ECG pearls
- Think of ApHCM when marked precordial voltage accompanies deep, often symmetric precordial T-wave inversion.
- T-wave inversion may extend into inferior and lateral leads; the distribution is variable.
- The ECG is a screening clue. Apical morphology must be confirmed with imaging.
- If the apex is poorly seen on TTE, consider contrast enhancement or CMR rather than accepting a falsely reassuring study.
- The “ace-of-spades” LV cavity is a structural imaging sign, not an ECG sign.
- Do not let a suspected chronic HCM pattern delay assessment of possible acute coronary syndrome.
12. Quick reference summary
| Question | Take-home point |
|---|---|
| Classic ECG clue | Deep/giant T-wave inversion in precordial leads, often with large precordial voltage. |
| Other lead involvement | Inferior and lateral T-wave inversion may also be present. |
| Is ECG diagnostic? | No. It suggests the phenotype but cannot confirm apical hypertrophy. |
| Structural hallmark | Predominant apical LV hypertrophy; possible apical cavity obliteration and “ace-of-spades” configuration. |
| Best next test | TTE initially; contrast echo or CMR when the apex is inadequately visualised or findings are inconclusive. |
| Important mimics | ACS/ischaemia, other HCM phenotypes, hypertensive LVH, Takotsubo and myocarditis. |
| Risk assessment | Base decisions on symptoms, family history, imaging, ventricular function and rhythm monitoring—not T-wave depth alone. |